LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Home・Aktien・Achieve Life Sciences Inc

Achieve Life Sciences Inc

Geschlossen

2.9 -3.01

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.83

Max

2.99

Schlüsselkennzahlen
By Trading Economics
Einkommen	109K -13M
Gewinnspanne	-5,421.053
Angestellte	25
EBITDA	-367K -12M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+389.93% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Nov. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	41M 169M
Vorheriger Eröffnungskurs	5.91
Vorheriger Schlusskurs	2.9

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

2.325 / 2.64 Unterstützung & Widerstand

Achieve Life Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Sept. 2025, 23:07 UTC

Akquisitionen, Fusionen, Übernahmen

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2. Sept. 2025, 22:10 UTC

Wichtige Markttreiber

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2. Sept. 2025, 21:47 UTC

Ergebnisse

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2. Sept. 2025, 16:52 UTC

Wichtige Markttreiber

CleanCore Solutions Shares Drop After $175 Million Private Investment

2. Sept. 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2. Sept. 2025, 21:40 UTC

Akquisitionen, Fusionen, Übernahmen

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2. Sept. 2025, 21:07 UTC

Ergebnisse

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2. Sept. 2025, 21:07 UTC

Ergebnisse

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q Rev $17.35B >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q Adj EPS 78c >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q EPS 82c >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q Net $782.5M >ATD.T

2. Sept. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2. Sept. 2025, 20:53 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2. Sept. 2025, 20:51 UTC

Akquisitionen, Fusionen, Übernahmen

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2. Sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. Sept. 2025, 20:27 UTC

Ergebnisse

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2. Sept. 2025, 20:24 UTC

Akquisitionen, Fusionen, Übernahmen

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2. Sept. 2025, 20:18 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2. Sept. 2025, 20:17 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2. Sept. 2025, 20:16 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2. Sept. 2025, 20:16 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2. Sept. 2025, 20:15 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2. Sept. 2025, 19:55 UTC

Ergebnisse

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2. Sept. 2025, 19:50 UTC

Akquisitionen, Fusionen, Übernahmen

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2. Sept. 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2. Sept. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2. Sept. 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2. Sept. 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2. Sept. 2025, 16:57 UTC

Akquisitionen, Fusionen, Übernahmen

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer-Vergleich

Kursveränderung

Achieve Life Sciences Inc Prognose

Kursziel

By TipRanks

389.93% Vorteil

12-Monats-Prognose

Durchschnitt 14.6 USD 389.93%

Hoch 20 USD

Tief 10 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Achieve Life Sciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Achieve Life Sciences Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

2.325 / 2.64Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

There is one bearish event.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.